Chuck Padala | LifeSci Advisors |
Dror Bashan | President, CEO |
Eyal Rubin | SVP, CFO |
Boobalan Pachaiyappan | H.C. Wainwright |
John Vandermosten | Zacks |
Greetings, and welcome to the Protalix BioTherapeutics Third Quarter 2022 Financial and Business Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce to your host, Mr. Chuck Padala of LifeSci Advisors, Investor Relations for Protalix. Sir, you may begin your conference.